Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women

Inclusion criteria

• . Participant having signed an Informed Consent Form (ICF);
• . Healthy female Participant aged 45 to 70 years inclusive not followed by a healthcare practitioner for any skin disease;
• . Participant with phototype II to IV according to the Fitzpatrick classification;
• . Participant with dry skin measured on the cheeks (Tewameter, TEWL \>15g/m²/h (skin barrier integrity) on back of the cheekbone)
• . Female Participant of non-childbearing potential, defined as a woman without uterus and/or both ovaries, surgically sterile (at least 6 months prior to Screening visit) or post-menopausal (at least one year post cessation of menses);
• . Female Participant of childbearing potential who has been using a highly effective birth control method for at least 1 month prior to Screening visit and agreeing to continue adequate contraception during the entire study period;
• . Participant agreeing not to apply any cosmetic product (e.g. care cream, lotion, body milk) or drug on the face (except usual cleansing products) within 24 hours before the study visits;
• . Participant agreeing to not apply cosmetic, medical, or aesthetic treatments out of the study protocol on the face and legs during the whole study duration;

Exclusion criteria